ELOXX PHARMACEUTICALS INC NEW
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ELOXX PHARMACEUTICALS INC NEW Com, CUSIP 29014R202.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for ELOXX PHARMACEUTICALS INC NEW Com, CUSIP 29014R202.